Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.31 USD | +2.84% | -0.63% | +32.24% |
May. 13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 831M | Sales 2025 * | 896M | Capitalization | 2.29B |
---|---|---|---|---|---|
Net income 2024 * | -92M | Net income 2025 * | -64M | EV / Sales 2024 * | 2.64 x |
Net cash position 2024 * | 93.93M | Net cash position 2025 * | 116M | EV / Sales 2025 * | 2.42 x |
P/E ratio 2024 * |
-27
x | P/E ratio 2025 * |
-36.1
x | Employees | 2,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.91% |
Latest transcript on Myriad Genetics, Inc.
1 day | +2.84% | ||
1 week | -0.63% | ||
Current month | +29.33% | ||
1 month | +36.81% | ||
3 months | +8.86% | ||
6 months | +41.63% | ||
Current year | +32.24% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 20-08-12 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | Jan. 28 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 09-09-15 |
Paul Bisaro
BRD | Director/Board Member | 63 | 22-10-30 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.24% | 14 M€ | -3.66% | ||
0.26% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 25.29 | +2.76% | 598,558 |
24-05-16 | 24.61 | -0.20% | 899,188 |
24-05-15 | 24.66 | -2.76% | 1,410,760 |
24-05-14 | 25.36 | +1.72% | 1,307,022 |
24-05-13 | 24.93 | -2.12% | 1,205,413 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.24% | 2.29B | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.91B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
-3.55% | 1.89B | |
+3.02% | 1.6B |
- Stock Market
- Equities
- MYGN Stock